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1. Introduction
Over the past 50 decades, porous materials, from zeolites, coordination polymers to metal
organic frameworks (MOFs), have gained considerable attention. The interesting feature is
their porosity that allows the diffusion of guest molecules into the bulk structure. The shape
and size of pores govern the shape and size selectivity of the guests to be incorporated. MOFs
as defined by Yaghi et al. are porous structures constructed from the coordinative bonding
between metal ions and organic linkers or bridging ligands (Figure 1) [1]. MOFs are formed
by anchoring metal‐containing units or secondary‐building units (SBUs) with organic linkers,
by coordination,  yielding open frameworks  that  show exceptional  feature  of  permanent
porosity,  stable  framework,  enormous surface  area,  and pore  volume.  The porosity  is  a
consequence of long organic linkers that confer large storage space and numerous adsorp‐
tion sites within MOFs. They also bear the ability to systematically vary and functionalize their
pore structure [2, 3]. In the history of MOFs, a benchmark was represented by the synthesis
of MOF‐5 (Zn4O(bdc)3, bdc = terephthalate) and HKUST‐1 (Cu3(btc)2, btc = 1,3,5‐benzenetri‐
carboxylate) with high porosity and low pressure gas sorption, followed by the develop‐
ment  of  chromium(III)  terephthalate  (MIL‐101)  with  high  chemical  stability,  MOF‐74
(Zn2(dhbdc),  dhbdc = 2,5‐dihydroxy‐1,4‐benzenedicarboxylate)  with  low  pressure  adsorp‐
tion of CO2, and several isostructural analogs of Mg‐MOF‐74 termed as IRMOF‐74‐I to IRMOF‐
74‐XI,  with  large  pore  apertures  to  accommodate  protein,  NU‐110E  with  acetylene‐
expanded hexatopic linker, having material highest experimental Brunauer‐Emmett‐Teller
(BET) surface area of any porous material reported to date (7140 m2 g-1) Some examples of
MOFs and their applications are given in Table 1 [1–15].
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Figure 1. Structure of MOF.
Application MOF  Metal  Ligand Year Author Rf
Drug delivery MIL‐101 [Cr3O(OH,F,H2O)3(1,4‐bdc)3
and MIL‐100
Cr  1,4‐benzenedicarboxylate
moieties (bdc) or H3btc:
Benzene‐1,3,5‐tricarboxylate
2006 Patricia
Horcajada et al.
[4]
Methane
Storage
MOF‐5 Zn4(1,4‐bdc)3 Zn bdc 2002 Li and
Eddaoudi, et al.
[5, 6]
Adsorption
and storage
HKUST( Hong Kong University of
Science and Technology)‐1
Cu2(H2O)2(CO2)4
Cu H3btc 2006 Rowsell and
Yaghi [7]
Adsorption
and storage
IRMOF‐9 Zn4O(bpdc)3 Zn 4,4′‐biphenyldicarboxylate
(bpdc)
2006 Rowsell and
Yaghi [7]
Adsorption
and storage
MOF‐74, Zn2(C8H2O6) Zn 2,5‐dihydroxybenzene‐1,4‐
dicarboxylic acid
2006 Rowsell and
Yaghi [7]
– (In) MIL‐68‐NH2 or IHM‐2 In bdc‐NH2: 2‐
aminoterephthalates
2011 Savonnet and
Farrusseng [8]
Drug
delivery
metal–organic Zn(bix) spheres with
encapsulated DOX [DOX/Zn(bix)],
SN‐38 [SN‐38/Zn(bix)], CPT [CPT/
Zn(bix)] and DAU [DAU/Zn(bix)]
Doxorubicin (DOX), SN‐38,
camptothecin (CPT) and daunomycin
(DAU) 
Zn Bix: 1,4-bis(imidazol-1-
ylmethyl)benzene
2010 Inhar Imaz et al.
[9]
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Application MOF  Metal  Ligand Year Author Rf
Soft
coupling–
deprotection
sequence
(In) MIL‐68‐NH‐ProFmoc and (In)
MIL‐68‐NH‐Ala‐FmocIn
*fluorenylmethyloxycarbonyl group
(Fmoc), a base‐label protecting group
for amines
In Amino acid such as L‐proline
(Pro‐OH) and D‐alanine
(Ala‐OH)
2011 Jerome Canivet
et al. [10]
Antibacterial Cu‐BTC(MOF‐199) Cu H3btc 2014 Rodrıguez et al.
[11]
Highly potent
bacteriocidal
activity
Co‐TDM Co H8 tdm: tetrakis [(3,5‐
dicarboxyphenyl)‐
oxamethyl] methane
2012 Wenjuan
Zhuang et al.
[12]
Delivery of
nitric oxide
MIL‐100(Fe or Cr)
and MIL‐127(Fe)
Fe, Cr or
Fe
tricarboxylate or
tetracarboxylate
2014 Eubank et al.
[13]
Antibacterial Ag2(O‐IPA)(H2O)·(H3O) and
Ag5(PYDC)2(OH)
Ag HO‐H2ipa = 5‐
hydroxyisophthalic acid and
H2pydc = pyridine‐3, 5‐
dicarboxylic acid
2014 Xinyi Lu et al.
[14]
Adsorption of
CO2 over N2
Mn3(HCOO)6 ·DMF Mn 3‐nitrophthalic acid (H2npta)
and 4,4′‐bipyridine (4,4′‐
bipy)
2014 Ying‐Ping Zhao
et al. [15]
Table 1. Some examples of MOFs and their applications.
2. Chemistry
MOFs consist of both inorganic and organic units. The organic units (linkers/bridging ligands)
consist of carboxylates, or anions, such as phosphonate, sulfonate, and heterocyclic com‐
pounds (Figures 2 and 3). The inorganic units are the metal ions or clusters termed as SBUs.
Its geometry is determined by the coordination number, coordination geometry of the metal
ions, and the nature of the functional groups. A variety of SBU geometries with different
number of points of extension such as octahedron (six points), trigonal prism (six points),
square paddle‐wheel (four points), and triangle (three points) have been observed in MOF
structures (Figure 4). In principle, a bridging ligand (ditopic, tritopic, tetratopic, or multitop‐
ic linkers) reacts with a metal ion with more than one vacant or labile site. The final frame‐
work topology of MOF is governed by both SBU connectors and organic ligand linkers.
Depending upon the nature of the system used, infinite‐extended polymeric or discrete‐closed
oligomeric structures can arise (Figure 4). Metal‐containing units and organic linkers can be
varied resulting in a variety of MOFs, tailored for different applications [3]. MOFs with large
spaces may result in the formation of interpenetrating structures. Thus, it is very important to
inhibit interpenetration by carefully choosing the organic linkers. The pore size is allowed to
be tuned and spatial cavity arrangement be controlled, by judicious selection of metal centers
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and organic ligands and also by adjusting their conditions of synthesis. The large porosity
allows their applications in adsorption and separation of gaseous molecules, catalysis,
microelectronics, optics, sensing applications, bioreactors, drug delivery, and others. MOFs
have pore openings up to 2‐nm size, which can accommodate small molecules. However, the
pore openings rarely allow the inclusion of large molecules (e.g., proteins and enzymes).
Attempts have been taken to increase the pore size to mesopore regime (pore size of 2–50 nm)
and to decrease the crystal size to the nanometer scale. The large pore aperture benefits surface
modification with a number of functionalities, without sacrificing the porosity of MOFs, also
allowing the encapsulation of large molecule MOFs. The synthesis of MOFs involves reac‐
tion conditions and simple methods such as solvothermal, ionothermal, diffusion, micro‐
wave methods, ultrasound‐assisted, template‐directed syntheses, and others [2, 3].
An interesting and significant advancement in the field is to combine MOFs with functional
nanoparticles, yielding new nanocomposite materials with unparalleled properties and
performance. Nano‐MOFs are advantageous over conventional nanomedicines owing to their
structural and chemical diversity, high loading capacity, and biodegradability. The final
properties are dependent on the particle composition, size, and morphology. These can be
obtained as either crystalline or amorphous materials. As soft porous crystals, framework
flexibility (triggered by an external stimulus, e.g., mechanical stress, temperature, light
interactions) may be shown by MOFs, also in the absence of guests or with no involvement of
adsorption and desorption [1–3, 16].
Figure 2. Some examples of organic ligands with carboxylic functionality used for the preparation of MOFs.
Metal-Organic Frameworks6
Figure 3. Some examples of ligands containing nitrogen, sulfur, phosphorous and heterocycles used for the prepara‐
tion of MOFs.
Figure 4. MOFs resulting from different metal nodes and bridging ligands.
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3. Metal biomolecule frameworks (BioMOFs)
Biomolecules are naturally and abundantly available. They are cost‐effective, rigid, and flexible
with different coordination sites, rendering structurally diverse, biologically compatible
MOFs. MOFs have also been synthesized from nontoxic endogenous cations (such as Ca, Mg,
Fe, and Zn) and ligands consisting of naturally occurring derivatives or biomolecules [17].
These BioMOFs are usually biocompatible and suitable for biomedical applications [17–47].
Such combinations of natural ligands with endogenous cations are also associated with several
therapeutic effects (anti‐allergic, anti‐inflammatory, antimicrobial, anticarcinogenic activi‐
ties). Table 2 shows some examples of BioMOFs and their applications [18–47]. Such biologi‐
cally and environmentally compatible MOFs are designed and constructed based on specific
composition criteria governed by judiciously selecting metal ions and organic linkers as
building blocks, which are nontoxic and biologically and environmentally compatible.
Biomolecules such as amino acids, peptides, proteins, nucleobases, carbohydrates, and other
natural products such as cyclodextrins, porphines, and some carboxylic acids (Figure 5) serve
as emerging building blocks for the design and construction of metal‐biomolecule frame‐
works with novel and interesting properties and applications that cannot be obtained through
the use of traditional organic linkers [17, 43, 44, 48, 49].
Aplication BioMOF Metal Ligand Year  AuthorRf
Ar and CH4 sorption [Cu(trans‐fum)] Cu Fum:Fumaric acid 2001 K. Seki et al
[18]
Reversible H2O
sorption/desorption
[Ni7(suc)6(OH)2
(H2O)2·2H2O
Ni Suc: Succinic
acid
2002 Forster et al.
[19]
– [Ni7(suc)4(OH)6
(H2O)3]·7H2O
Ni Suc 2003 Guillou et al.
[20]
Sorption of more
than 30 kinds of
guests (e.g. DMF,
benzene,etc.);
structural change
[Mn3(HCOO)6]
·(CH3OH)
·(H2O)
Mn Formic acid 2004 Wang et al.
[21]
Selective CO2
and H2 sorption
Mn(HCOO)2·1/3
(C4H8O2)
Mn Formic
acid
2004 Dybtsev et al.
[22]
Adsorption Fe3O(MeOH)3(fum)3
(CO2CH3)]·4.5MeOH
Fe Fum 2004 Serre et al.
[23]
1,3‐Butanediol
sorption
[Ni2O(L‐Asp)
H2O]·4H2O
Ni Amino acid L‐Asp:L‐
aspartic acid
2004 Anokhina et al.
[24]
Enantioselective
separation and
catalytic
Zn2(bdc)
(L‐lac)(DMF)
Zn bdc: 1,4‐
benzendicarboxylic
acid and L‐
lac:Lactic acid
2006 Dybtsev et al.
[25]
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Aplication BioMOF Metal Ligand Year  AuthorRf
CO2 sorption [Ni2(L‐Asp)2
(4,4′‐bipy)]
·2H2O
Ni L‐Asp and
4,4′‐bipy : 1,2‐bis
(4‐pyridyl)ethane
2006 Vaidhyanathan
et al. [26]
H2 sorption Co2(L‐Asp)2
(4,4′‐bipy)]·2H2O
Co L‐Asp and 4,4′
‐bipy
2008 Zhu et al.
[27]
Heterogeneous
asymmetric
catalysts for
the methanolysis
of rac‐propylene
oxide
Ni2(L‐Asp)2
(4,4′‐bipy)
·(HCl)1.8(MeOH)
Ni L‐Asp and 4,
4′‐bipy
2008 Ingleson
et al. [28]
Heterogeneous
asymmetric
catalysts for
the methanolysis
of rac‐propylene
oxide
Cu2(L‐Asp)2
(bpe)·(HCl)2·
(H2O)2
Cu L‐Asp
and bpe: 1,2‐bis(4‐
pyridyl)ethane
2008 Ingleson
et al. [28]
Cation exchange
capabilities,
including
cationic drugs
and lanthanide
ions
Zn8(Ade)4(bpdc)6O·2
Me2NH2·
8DMF·11H2O
Zn Nucleobases
Adenine:Ade
and bpdc:
biphenyldicarboxylate
2009 An et al.
[29]
Selective
CO2. sorption
Co2(Ade)2(CO2CH3)2
·2DMF· 0.5H2O
Co Ade 2010 An et al.
[30]
Drug delivery
and imaging
Fe3O(MeOH)3(fumarate)3‐
(CO2CH3)]·4.5
MeOH and [Fe3O(MeOH)
(C6H4O8)3Cl]·6MeOH
Fumarate and C6H4O8
is galactarate
2010 Horcajada
et al. [31]
Therapeutic agent BioMIL-1 Fe Nicotinic acid (pyridine-3-
carboxylic acid, also called
niacin or vitamin B3)
2010 Miller et al.
[32]
Reversible
flexible structure;
CO2, MeOH and
H2O sorption
[Zn(GlyAla)2]·(solvent) Zn Peptide,
Glycine‐adenine
2010 Rabone et al.
[33]
(γ‐CD)
(KOH)2
K Saccharides
γ ‐CD: cyclodextrins
2010 Smaldone et al.
[35]
Inclusion of
several molecules
(e.g. Rhodamine B,
(γ‐CD)
(RbOH)2
Rb γ‐CD
γ‐CD is a (chiral) cyclic
oligosaccharide
2010 Smaldone et al.
[34]
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Aplication BioMOF Metal Ligand Year  AuthorRf
4‐phenylazoplenol,etc.) composed of
eightR‐1,4‐
linkedD‐
glucopyranosyl
(R‐1,4‐D‐Glup)
Highly selective
adsorption of CO2
CD‐MOF‐2 Rb γ‐CD 2011 Jeremiah J.
Gassensmith et al.
[35]
Photostable O2
sensor
Zn8(Ade)4(bpdc)6·
O·2Me2NH2] loaded
with lanthanide
cations( Tb(III),
Sm(III), Eu(III)
and Yb(III))
Zn and
lanthanide
Ade and bpdc 2011 An et al.
[36]
– M(II/III)
Gallates
Fe, Mn, Co
and Ni
H4gal: gallic
acid
2011 Saines et al.
[37]
Porous α‐CD‐MCF Rb α‐CD
R‐cyclodextrin
(R‐CD),
comprised of
sixR‐1,4‐
D‐Glupresidues
portrayed in
their stable
4C1 conformations
2012 Gassensmith
et al. [38]
Adsorption CD‐MOF‐1
and CD‐MOF‐2
CD‐MOF‐3
K, Rb and
Cs
γ‐CD 2012 Forgan et al.
[39]
Drug storage
and release
or for the
immobilization
and organization
of large biomolecules
Bio‐MOF‐100 Zn Ade 2012 Jihyun An
et al. [40]
– MIL‐151 to ‐154 Zr H4gal 2014 Cooper et al.
[41]
Antibacterial BioMIL‐5 Zn AzA: azelaic
acid
2014 Tamames‐Tabar
et al. [42]
Antioxidant
carrier
Mg(H4gal) Mg H4gal 2015 Cooper et al.
[43]
Inclusion and CD‐MOF‐1 Na β‐CD: 2015 Lu et al.
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Aplication BioMOF Metal Ligand Year  AuthorRf
loading the
drug molecules
cyclodextrins [44]
Electrochemical
nitrite
detection
MOF‐525 Zr H4tcpp: meso‐tetra
(4‐carboxyphenyl)
porphine
2015 Kung et al.
[45]
Ammonia uptake Al‐PMOF Al H4tcpp 2015 Wilcox et al.
[46]
Highly active
anti‐diabetic
activity
[Zn(ain)(atz)]n Zn Hatz : 5‐
aminotetrazole
and Hain: 2‐
amino‐4‐isonicotinic
2016 David Briones
et al. [47]
Table 2. Some examples of BioMOFs and their applications.
Figure 5. Examples of organic linkers used for the synthesis of BioMOFs.
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4. Summary
MOFs find versatile applications as drug‐delivery agents, sensors, storage and separation
systems, catalysts, and others. Nontoxic nano‐MOFs bearing tailored cores and surfaces can
be used as nanodrug carriers for antitumor and anti‐HIV drugs (biomedicine, nontoxic, drug).
MOFs with biomolecules as organic linkers are still in cradle stage in contrast to their
counterparts bearing traditional organic linkers. However, biomolecules confer biological
compatibility and easy recyclability to MOFs. They also confer unique characteristics such as
chirality and specific recognition, self‐assembly characteristic, separation, ion exchange, and
catalytic properties, also rendering bioinspired structures. In future, a better understanding
and control of chemistry and design of MOFs may provide plethora of opportunities to‐
wards their structures, properties, and applications in different fields.
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